Watson-Marlow is pleased to announce that construction will start in October 2021, on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022.
Pharmacy News Articles
Phillips-Medisize Increases Global Manufacturing Capacity
Phillips-Medisize, announces the expansion of its global manufacturing footprint, along with extended product design, development and manufacturing capabilities to streamline the delivery of game-changing products and solutions.
MilliporeSigma Launches New Contract Development Manufacturing Facility for Gene Therapy
MilliporeSigma today announced the opening of its second Carlsbad, California-based facility, significantly expanding its CDMO footprint.
Millstone Medical Outsourcing Expands Medical Device Cleanroom
Millstone Medical Outsourcing has officially broken ground on its new 56,385 square foot facility in Fall River, MA. The MA headquarter campus will now hold a total of 124,367 square feet of production space, including its existing 15,000 square feet of class 10,000/ISO7-rated cleanroom space for medical device packaging operations.
Pepscan Doubles GMP Production Capacity to Facilitate Clients’ Growth
Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides.
GE Healthcare and Germfree unveil collaboration to advance modular manufacturing of novel biotherapeutics
GE Healthcare Life Sciences and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy.
VetStem Biopharma Secures FDA Approval of First Human IND
VetStem Biopharma, a veterinary and human regenerative medicine CRO, used its extensive experience, FDA master files, and database of veterinary stem cell therapy to secure FDA approval of a human IND for stem cell therapy in patients with osteoarthritis. VetStem made the application to FDA on behalf of its subsidiary, Personalized Stem Cells, Inc.
Mile High Labs buys 400,000 sq ft pharmaceutical production facility
Mile High Labs, a Colorado startup that calls itself the world’s largest manufacturer of products, purchased the plant in Broomfield, Colorado, for about $18.8 million.
GSK Opens New Pharmaceutical Manufacturing Facilities worth $130m
Multinational pharmaceutical company GlaxoSmithKlyne (GSK) launched two new pharmaceutical manufacturing facilities and an expanded production building at its Jurong site. According to GSK, the new and expanded sites will allow the faster production of drugs and Active Pharmaceutical Ingredients (APIs) for clinical trials.
COPD Electronic Inhaler Monitoring
In one of the first-of-its-kind studies, Cleveland Clinic researchers found that the use of electronic inhaler monitoring, in combination with a disease management program, is associated with reduced healthcare utilization in patients with chronic obstructive pulmonary disease (COPD).
Thermo Fisher Scientific to Invest $50 Million to Expand Bioproduction Capabilities
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems.
Romaco China gains a new processing laboratory
More than 500 invited guests and customers of Romaco China and Truking recently attended the official opening of the new “Romaco China Solids Process Centre”. This high-tech laboratory on the Truking campus in Changsha is equipped with Innojet and Kilian machines.